Chat with us
Research Assistance
Online
  • Please enter your first name.

Europe Synthetic Biology Market Size & Outlook, 2026-2033

The synthetic biology market in Europe is expected to reach a projected revenue of US$ 18,774.8 million by 2033. A compound annual growth rate of 16.6% is expected of Europe synthetic biology market from 2026 to 2033.

  • Biotechnology
    • Recombinant DNA & DNA Analysis
      • Synthetic Biology Market Outlook
Revenue, 2025 (US$M)
$5,516.4
Estimate, 2026 (US$M)
$6,403.8
Forecast, 2033 (US$M)
$18,774.8
CAGR, 2026 - 2033
16.6%
Europe Synthetic Biology Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the synthetic biology market

Every figure cited from GVR research

Europe synthetic biology market highlights

  • The Europe synthetic biology market generated a revenue of USD 5,516.4 million in 2025.
  • The market is expected to grow at a CAGR of 16.6% from 2026 to 2033.
  • In terms of segment, pcr technology was the largest revenue generating technology in 2025.
  • PCR Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 5,516.4 million
Market revenue in 2033USD 18,774.8 million
Growth rate16.6% (CAGR from 2026 to 2033)
Largest segmentPcr technology
Fastest growing segmentPCR Technology
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPCR Technology, Genome Editing Technology, NGS Technology, Bioprocessing Technology, Other Technologies
Key market players worldwideBasf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 29.1% of the global synthetic biology market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 18,684.3 million by 2033.

With strong synthetic biology research, rising support from the government and private sector, the Europe synthetic biology market is expected to grow significantly during the forecast period. The organization is supporting Synthetic Biology Accelerator (IBISBA) project and Industrial Biotechnology Innovation.

This funding is expected to accelerate uptake of industrial biotechnology. Moreover, European Synthetic Biology Society brings together synthetic biologists from Europe and other regions. EUSynBioS supports synthetic biology researchers in Europe through industrial and academic collaborations.

It promoted Europe synthetic biology space through annual conferences and collection & distribution of current news on the field, creating a network of investigators, academics, &industry representatives. These factors are anticipated to drive market growth during the forecast period.

No credit card required*

Publish Date: Feb 21, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Synthetic Biology Market Companies

NameProfile# EmployeesHQWebsite
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Basf SEView profile 111,855Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056www.basf.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Eurofins Scientific SEView profile 61,79823 Val Fleuri, Luxembourg, Luxembourg, L-1526www.eurofins.com
New England BiolabsView profile 501-1000Ipswich, Massachusetts, United States, North Americaneb.com
DNAstarView profile 51-100Madison, Wisconsin, United States, North Americawww.dnastar.com
Codexis IncView profile 174200 Penobscot Drive, Redwood, CA, United States, 94063www.codexis.com
SynthegoView profile 251-500Redwood City, California, United States, North Americawww.synthego.com
NovozymesView profile 5001-10000Bagsværd, Hovedstaden, Denmark, Europewww.novozymes.com/en#

Europe Synthetic Biology Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Synthetic Biology Market Outlook will help companies and investors design strategic landscapes.


Pcr Technology was the largest segment with a revenue share of 34.92% in 2025.

Horizon Databook has segmented the Europe synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.




With strong synthetic biology research, rising support from the government and private sector, the Europe synthetic biology market is expected to grow significantly during the forecast period. The organization is supporting Synthetic Biology Accelerator (IBISBA) project and Industrial Biotechnology Innovation.

This funding is expected to accelerate uptake of industrial biotechnology. Moreover, European Synthetic Biology Society brings together synthetic biologists from Europe and other regions. EUSynBioS supports synthetic biology researchers in Europe through industrial and academic collaborations.

It promoted Europe synthetic biology space through annual conferences and collection & distribution of current news on the field, creating a network of investigators, academics, &industry representatives. These factors are anticipated to drive market growth during the forecast period.

  • Europe Synthetic Biology Market Technology Outlook (Revenue, USD Million , 2021-2033)
    • PCR Technology
    • Genome Editing Technology
    • NGS Technology
    • Bioprocessing Technology
    • Other Technologies
  • Europe Synthetic Biology Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Enzymes
    • Oligonucleotide/Oligo Pools and Synthetic DNA
    • Cloning Technologies Kits
    • Xeno-Nucleic Acids
    • Chassis Organism
  • Europe Synthetic Biology Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Healthcare
    • Non-healthcare
  • Europe Synthetic Biology Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Biotechnology and Pharmaceutical companies
    • Academic and Government Research Institutes
    • Others

Reasons to subscribe to Synthetic Biology Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Synthetic Biology Market Outlook databook

  • Our clientele includes a mix of Synthetic Biology Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Synthetic Biology Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Synthetic Biology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Europe Synthetic Biology Market, 2021-2033 (US$M)

No Access Stack Chart

Europe synthetic biology market statistics, by technology, 2021-2033 (US$M)

No Access Pie Chart

Europe synthetic biology market statistics, by country, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more